AFFLUENT Competitors

0JZ Stock

3.33 0.13 3.76%

AFFLUENT MEDICAL SAS competes with Mizuno, Sony Group, MITSUBISHI KAKOKI, ROMERIKE SPAREBANK, and HITACHI CONSTRMACHADR/2; as well as few others. The company classifies itself under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing AFFLUENT MEDICAL competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of AFFLUENT MEDICAL to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out AFFLUENT MEDICAL Correlation with its peers.

AFFLUENT MEDICAL vs Yamaha Correlation

Poor diversification

The correlation between AFFLUENT MEDICAL SAS and YHA is 0.67 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding AFFLUENT MEDICAL SAS and YHA in the same portfolio, assuming nothing else is changed.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
0.17	3.45	13.81

Details

Intrinsic

Valuation

Low	Real	High
0.15	2.93	13.29

Details

AFFLUENT MEDICAL Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between AFFLUENT MEDICAL and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of AFFLUENT and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of AFFLUENT MEDICAL SAS does not affect the price movement of the other competitor.

	MIZ	SON1	893	92I	HCMA	BFP	YHA
MIZ		-0.7	0.14	0.73	0.79	0.52	0.84	MIZ
SON1	-0.7		-0.03	-0.81	-0.69	-0.84	-0.64	SON1
893	0.14	-0.03		-0.08	0.29	0.03	0.29	893
92I	0.73	-0.81	-0.08		0.67	0.7	0.58	92I
HCMA	0.79	-0.69	0.29	0.67		0.45	0.78	HCMA
BFP	0.52	-0.84	0.03	0.7	0.45		0.44	BFP
YHA	0.84	-0.64	0.29	0.58	0.78	0.44		YHA
	MIZ	SON1	893	92I	HCMA	BFP	YHA

High positive correlations

YHA	+ 0.84	MIZ
HCMA	+ 0.79	MIZ
YHA	+ 0.78	HCMA
92I	+ 0.73	MIZ
BFP	+ 0.7	92I
HCMA	+ 0.67	92I

High negative correlations

BFP	- 0.84	SON1
92I	- 0.81	SON1
SON1	- 0.7	MIZ
HCMA	- 0.69	SON1
YHA	- 0.64	SON1
92I	- 0.08	893

Risk-Adjusted Indicators

There is a big difference between AFFLUENT Stock performing well and AFFLUENT MEDICAL Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AFFLUENT MEDICAL's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MIZ	1.80	0.46	0.20	1.22	1.55	(2.36)	4.86	(3.18)	11.31
SON1	1.37	(0.26)	0.00	0.58	0.00	0.00	2.51	(2.94)	9.80
893	2.01	(0.08)	0.00	(0.09)	0.00	0.00	4.02	(5.08)	13.77
92I	0.66	0.11	(0.01)	(0.39)	0.89	(0.71)	1.32	(1.08)	8.68
HCMA	2.14	0.38	0.08	(3.22)	2.93	(2.52)	6.35	(3.29)	13.21
BFP	2.90	0.21	0.02	(0.42)	3.59	(3.08)	8.16	(6.68)	18.93
YHA	1.44	0.02	0.01	0.11	2.26	(1.57)	3.23	(3.12)	13.58

AFFLUENT MEDICAL Competitive Analysis

The better you understand AFFLUENT MEDICAL competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, AFFLUENT MEDICAL's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across AFFLUENT MEDICAL's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	0JZ	MIZ	SON1	893	92I	HCMA	BFP	YHA
	3.76 3.33 AFFLUENT	10.20 21.60 Mizuno	1.22 19.36 Sony	1.08 18.80 MITSUBISHI	0.57 12.38 ROMERIKE	0.72 70.00 HITACHI	2.67 15.40 BBVA	1.07 6.61 Yamaha
Market Volatility (90 Days Market Risk)	Dangerous	Very steady	Very steady	Not too volatile	Not too volatile	Very steady	Somewhat reliable	Somewhat reliable
Market Performance (90 Days Performance)	Good	Solid	Weakest	Soft	Mild	Solid	Fair	Fair
Odds of Financial Distress (Probability Of Bankruptcy)	Moderate	Tiny	Moderate	Low	Low	Low	Low	Tiny
Current Valuation (Equity Enterprise Value)	Over Valued	Under Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Hold	Strong Buy	Strong Sell	Strong Sell	Strong Sell	Strong Sell	Strong Sell	Sell
Current Ratio	N/A	2.91 X	0.64 X	2.07 X	N/A	1.73 X	N/A	3.23 X
Net Asset	N/A	218.48 B	35.29 T	N/A	N/A	N/A	14.72 T	591.28 B
Profit Margin	(2.80) %	0.07 %	(0.02) %	0.09 %	0.45 %	0.06 %	0.09 %	0.04 %
EBITDA	(12.89 M)	25.09 B	2.04 T	9.34 B	N/A	217.43 B	N/A	55.5 B
Operating Margin	(15.76) %	0.09 %	0.14 %	0.10 %	0.57 %	0.09 %	0.09 %	0.1 %
Current Valuation	236.5 M	1.5 B	111.76 B	396.96 M	5.95 B	9.83 B	(354.15 B)	2.46 B
Price To Book	10.24 X	1.84 X	2.66 X	1.93 X	0.17 X	1.58 X	1.74 X	1.14 X
Retained Earnings	N/A	83.12 B	6.68 T	N/A	N/A	N/A	(367.21 B)	438.45 B
Five Year Return	N/A	1.87 %	0.54 %	N/A	N/A	N/A	N/A	1.25 %
Beta	0.79	0.17	0.7	0.57	0.033	0.65	0.35	0.11
Number Of Employees	76	3.65 K	112.3 K	1.02 K	77	26.1 K	6.29 K	18.95 K
Shares Outstanding	59.2 M	76.78 M	5.96 B	22.76 M	2.84 M	106.37 M	204.24 M	447.44 M
Cash Flow From Operations	N/A	7.01 B	2.32 T	(2.59 B)	N/A	76.59 B	2.59 T	36.02 B
Annual Yield	N/A	0.02 %	0.01 %	0.04 %	0.07 %	0.03 %	0.02 %	0.02 %
Total Debt	N/A	5.88 B	2.13 T	3.3 B	2.94 B	398.93 B	12.1 T	5.55 B
Return On Equity	-0.63	0.11	0.15	0.17	0.0912	0.0961	0.0719	0.0399
Return On Asset	-0.16	0.0626	0.0396	0.0757	0.0115	0.0469	0.0111	0.0407
Book Value Per Share	0.54 X	3.70 X	7.45 X	9.72 X	67.56 X	22.29 X	2.83 X	5.79 X
Total Asset	N/A	218.48 B	35.29 T	N/A	N/A	N/A	14.72 T	591.28 B
Debt To Equity	N/A	0.13 %	0.39 %	0.13 %	N/A	0.69 %	N/A	0.07 %
Last Dividend Paid	N/A	N/A	22.5	93.33	10.5	185.0	N/A	25.67
Target Price	N/A	N/A	N/A	N/A	N/A	N/A	3.83	N/A
Shares Owned By Institutions	40.00 %	28.90 %	48.34 %	25.20 %	9.91 %	N/A	8.60 %	52.53 %
Market Capitalization	204.85 M	1.68 B	115.42 B	433.53 M	36.29 M	7.75 B	3.27 B	2.96 B
Price To Earning	N/A	17.18 X	13.42 X	6.88 X	1.27 X	63.22 X	5.57 X	46.99 X
Price To Earnings To Growth	N/A	N/A	3.13 X	N/A	N/A	1.25 X	N/A	N/A
Price To Sales	38.90 X	0.01 X	0.01 X	0.01 X	0.08 X	0.01 X	0 X	0.01 X
Net Income	N/A	15.24 B	1.14 T	2.51 B	20.99 M	17.27 B	360.41 B	13.35 B
Earnings Per Share	(0.34) X	1.19 X	1.11 X	1.44 X	6.53 X	4.44 X	0.54 X	0.21 X
Shares Owned By Insiders	14.52 %	23.78 %	0.07 %	10.52 %	44.98 %	N/A	N/A	2.84 %
Revenue	5.27 M	240.34 B	12.96 T	77.16 B	468.03 M	1.36 T	3.43 T	462.08 B
Working Capital	N/A	104.85 B	(3.23 T)	N/A	N/A	N/A	N/A	245.28 B
Cash And Equivalents	N/A	24.61 B	1.16 T	7.05 B	895.6 M	94.06 B	175.55 B	147.57 B
Cash Per Share	N/A	963.41 X	938.13 X	928.62 X	895.60 X	884.66 X	859.56 X	839.42 X
Gross Profit	916 K	101.93 B	3.88 T	16.57 B	468.03 M	414.11 B	2.05 T	166.82 B
Day Typical Price	3.39	21.6	19.4	18.8	12.38	70.17	15.4	6.61
Accumulation Distribution	291.94	N/A	882.27	N/A	N/A	0.0071	N/A	N/A
Market Facilitation Index	1.0E-4	N/A	0.0	N/A	N/A	0.5	N/A	N/A
Daily Balance Of Power	(0.42)	9.2 T	(0.34)	9.2 T	9.2 T	1.0	9.2 T	9.2 T
Period Momentum Indicator	(0.13)	2.0	(0.24)	0.2	0.07	0.5	0.4	0.07
Rate Of Daily Change	0.96	1.1	0.99	1.01	1.01	1.01	1.03	1.01
Day Median Price	3.42	21.6	19.42	18.8	12.38	70.25	15.4	6.61
Price Action Indicator	(0.15)	1.0	(0.18)	0.1	0.035	N/A	0.2	0.035
Coefficient Of Variation	656.56	503.25	(599.63)	(9,715)	1064.22	824.1	2201.27	1759.65
Mean Deviation	4.7	1.8	1.37	2.01	0.6568	2.14	2.9	1.44
Jensen Alpha	1.44	0.4582	(0.26)	(0.08)	0.1054	0.3762	0.2069	0.022
Total Risk Alpha	0.3302	0.196	(0.53)	(0.36)	(0.03)	9.0E-4	(0.30)	(0.15)
Sortino Ratio	0.3397	0.2048	N/A	N/A	(0.01)	0.0754	0.0186	0.0109
Downside Variance	16.98	3.86	N/A	N/A	1.03	13.04	16.76	7.01
Standard Deviation	9.87	2.55	1.83	2.71	1.01	3.1	3.95	2.33
Kurtosis	17.07	2.94	1.99	0.6047	8.98	5.65	0.705	7.12
Potential Upside	7.27	4.86	2.51	4.02	1.32	6.35	8.16	3.23
Treynor Ratio	2.69	1.22	0.5777	(0.09)	(0.39)	(3.22)	(0.42)	0.1139
Maximum Drawdown	66.57	11.31	9.8	13.77	8.68	13.21	18.93	13.58
Variance	97.39	6.49	3.35	7.32	1.02	9.58	15.63	5.42
Market Risk Adjusted Performance	2.7	1.23	0.5877	(0.08)	(0.38)	(3.21)	(0.41)	0.1239
Risk Adjusted Performance	0.1299	0.1644	(0.13)	(0)	0.0766	0.1036	0.044	0.0516
Skewness	3.89	1.27	1.06	0.2336	0.4181	(0.68)	0.4641	(0.04)
Semi Deviation	3.01	1.55	N/A	N/A	0.8917	2.93	3.59	2.26
Information Ratio	0.1418	0.1581	(0.22)	(0.05)	(0.01)	0.0879	0.0193	0.0124
Value At Risk	(5.21)	(3.18)	(2.94)	(5.08)	(1.08)	(3.29)	(6.68)	(3.12)
Expected Short fall	(7.02)	(2.36)	N/A	N/A	(0.71)	(2.52)	(3.08)	(1.57)
Downside Deviation	4.12	1.97	N/A	N/A	1.01	3.61	4.09	2.65
Semi Variance	9.08	2.41	N/A	N/A	0.7951	8.58	12.91	5.12

AFFLUENT MEDICAL Competition Performance Charts

Five steps to successful analysis of AFFLUENT MEDICAL Competition

AFFLUENT MEDICAL's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by AFFLUENT MEDICAL SAS in relation to its competition. AFFLUENT MEDICAL's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of AFFLUENT MEDICAL in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact AFFLUENT MEDICAL's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to AFFLUENT MEDICAL SAS, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your AFFLUENT MEDICAL position

In addition to having AFFLUENT MEDICAL in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Manufacturing Thematic Idea Now

Manufacturing

Companies that provide goods across residential, commercial and industrial construction such as machinery, tools, or lumber production. The Manufacturing theme has 20 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Manufacturing Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in AFFLUENT Stock

AFFLUENT MEDICAL financial ratios help investors to determine whether AFFLUENT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AFFLUENT with respect to the benefits of owning AFFLUENT MEDICAL security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC